Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Guardant Health, Inc. (GH) vs ICON PLC (ICLR)

Guardant Health, Inc. and ICON PLC are both Diagnostics & Research companies. Guardant Health, Inc. is the larger, with a market value of $23.9B against $13.4B — 1.8× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; ICON PLC trades at 257×. Guardant Health, Inc. grew revenue faster over the last twelve months: 42.7% against 3.26%. ICON PLC has the higher net margin (0.51% vs −38.3%) and the higher return on invested capital (1.57% vs −129.7%). Across the 18 metrics below, Guardant Health, Inc. leads on 9 and ICON PLC on 9.

Valuation

Metric GH ICLR Diagnostics & Research median
P/E n/m 257.44 33.95
P/S 19.91 1.60 4.87
P/B n/m 1.41 3.12
Price to free cash flow n/m 14.98 34.02
EV/EBITDA n/m 23.55 25.20
EV/Sales 20.29 1.89 5.66
Earnings yield (1.97%) 0.39% (1.75%)
Free cash flow yield (1.10%) 6.67% (0.13%)

Profitability

Metric GH ICLR Diagnostics & Research median
Gross margin 65.01% 23.91% 50.89%
Operating margin (39.75%) 3.57% (8.57%)
Net margin (38.33%) 0.51% (6.37%)
Free cash flow margin (20.35%) 10.66% 0.00%
Return on equity 171.64% 0.45% (2.92%)
Return on assets (27.95%) 0.26% (6.71%)
Return on invested capital (129.70%) 1.57% 0.00%

Growth

Metric GH ICLR Diagnostics & Research median
Revenue growth (TTM) 42.74% 3.26% 7.69%
EPS growth (last fiscal year) 6.74% (69.57%) —
Revenue growth, 5-year CAGR 27.92% 24.15% 7.40%
Net income growth, 5-year CAGR 0.00% (7.15%) 0.00%

Health

Metric GH ICLR Diagnostics & Research median
Debt to equity (6.74) 0.36 0.11
Current ratio 4.03 0.95 2.02
Net debt to EBITDA (0.75) 3.34 0.78

Dividend

Metric GH ICLR Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric GH ICLR Diagnostics & Research median
Market cap 23.94b 13.42b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack